179 related articles for article (PubMed ID: 20814828)
1. Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency.
Henneman L; Schneiders MS; Turkenburg M; Waterham HR
J Inherit Metab Dis; 2010 Oct; 33(5):625-32. PubMed ID: 20814828
[TBL] [Abstract][Full Text] [Related]
2. Unprenylated RhoA contributes to IL-1β hypersecretion in mevalonate kinase deficiency model through stimulation of Rac1 activity.
van der Burgh R; Pervolaraki K; Turkenburg M; Waterham HR; Frenkel J; Boes M
J Biol Chem; 2014 Oct; 289(40):27757-65. PubMed ID: 25107911
[TBL] [Abstract][Full Text] [Related]
3. Molecular and cellular consequences of mevalonate kinase deficiency.
Politiek FA; Turkenburg M; Henneman L; Ofman R; Waterham HR
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167177. PubMed ID: 38636615
[TBL] [Abstract][Full Text] [Related]
4. HMG-CoA reductase inhibition induces IL-1beta release through Rac1/PI3K/PKB-dependent caspase-1 activation.
Kuijk LM; Beekman JM; Koster J; Waterham HR; Frenkel J; Coffer PJ
Blood; 2008 Nov; 112(9):3563-73. PubMed ID: 18684863
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases.
Zhu Y; Casey PJ; Kumar AP; Pervaiz S
Cell Death Dis; 2013 Apr; 4(4):e568. PubMed ID: 23559002
[TBL] [Abstract][Full Text] [Related]
6. Lack of Prenylated Proteins, Autophagy Impairment and Apoptosis in SH-SY5Y Neuronal Cell Model of Mevalonate Kinase Deficiency.
Tricarico PM; Romeo A; Gratton R; Crovella S; Celsi F
Cell Physiol Biochem; 2017; 41(4):1649-1660. PubMed ID: 28359055
[TBL] [Abstract][Full Text] [Related]
7. Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency.
Politiek FA; Waterham HR
Front Immunol; 2021; 12():724991. PubMed ID: 34539662
[TBL] [Abstract][Full Text] [Related]
8. Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency.
Schneiders MS; Houten SM; Turkenburg M; Wanders RJ; Waterham HR
Arthritis Rheum; 2006 Jul; 54(7):2306-13. PubMed ID: 16802371
[TBL] [Abstract][Full Text] [Related]
9. A role for geranylgeranylation in interleukin-1beta secretion.
Mandey SH; Kuijk LM; Frenkel J; Waterham HR
Arthritis Rheum; 2006 Nov; 54(11):3690-5. PubMed ID: 17075828
[TBL] [Abstract][Full Text] [Related]
10. Mevalonate kinase deficiency leads to decreased prenylation of Rab GTPases.
Jurczyluk J; Munoz MA; Skinner OP; Chai RC; Ali N; Palendira U; Quinn JM; Preston A; Tangye SG; Brown AJ; Argent E; Ziegler JB; Mehr S; Rogers MJ
Immunol Cell Biol; 2016 Nov; 94(10):994-999. PubMed ID: 27377765
[TBL] [Abstract][Full Text] [Related]
11. Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency.
Munoz MA; Jurczyluk J; Simon A; Hissaria P; Arts RJW; Coman D; Boros C; Mehr S; Rogers MJ
Front Immunol; 2019; 10():1900. PubMed ID: 31474985
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of simvastatin on various signal transduction intermediates in cultured human smooth muscle cells.
Nègre-Aminou P; van Erck M; van Leeuwen RE; Collard JG; Cohen LH
Biochem Pharmacol; 2001 Apr; 61(8):991-8. PubMed ID: 11286990
[TBL] [Abstract][Full Text] [Related]
13. Regulation of isoprenoid/cholesterol biosynthesis in cells from mevalonate kinase-deficient patients.
Houten SM; Schneiders MS; Wanders RJ; Waterham HR
J Biol Chem; 2003 Feb; 278(8):5736-43. PubMed ID: 12477733
[TBL] [Abstract][Full Text] [Related]
14. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
16. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
[TBL] [Abstract][Full Text] [Related]
17. Respiratory deficiency in yeast mevalonate kinase deficient may explain MKD-associate metabolic disorder in humans.
Santos MMS; Elsztein C; De Souza RB; Paiva SSL; Silva JA; Crovella S; De Morais MA
Curr Genet; 2018 Aug; 64(4):871-881. PubMed ID: 29374778
[TBL] [Abstract][Full Text] [Related]
18. Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation.
Normand S; Massonnet B; Delwail A; Favot L; Cuisset L; Grateau G; Morel F; Silvain C; Lecron JC
Eur Cytokine Netw; 2009 Sep; 20(3):101-7. PubMed ID: 19825518
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.
Tang D; Park HJ; Georgescu SP; Sebti SM; Hamilton AD; Galper JB
Life Sci; 2006 Sep; 79(15):1484-92. PubMed ID: 16740276
[TBL] [Abstract][Full Text] [Related]
20. Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency.
Mandey SH; Schneiders MS; Koster J; Waterham HR
Hum Mutat; 2006 Aug; 27(8):796-802. PubMed ID: 16835861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]